Trial Profile
Intranasal Ketamine Use in Autism Spectrum Disorder: A Placebo-Controlled Crossover Pilot Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2018
Price :
$35
*
At a glance
- Drugs Ketamine (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 10 Oct 2018 Status changed from recruiting to completed.
- 02 Jul 2018 New trial record